Literature DB >> 8904446

Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota.

P D Mitchell1, K D Reed, J M Hofkes.   

Abstract

In Wisconsin and Minnesota, Ixodes scapularis (Ixodes dammini) ticks are the vector of three microorganisms that may cause significant disease in humans and lower mammals. These diseases include Lyme borreliosis, which is caused by Borrelia burgdorferi, babesiosis, which is caused by Babesia microti, and human granulocytic ehrlichiosis (HGE), which is caused by an apparently new species in the genus Ehrlichia. Immunoserologic testing was performed on sera from patients with a diagnosis of one of these diseases to determine if there was evidence of coinfection with one or more of the other agents. Of 96 patients with Lyme borreliosis, 9 (9.4%) demonstrated immunoserologic evidence of coinfection: 5 (5.2%) with the agent of HGE, 2 (2.1%) with B. microti, and 2 (2.1%) with both microorganisms. Of 19 patients diagnosed with HGE, 3 (15.8%) showed immunoserologic evidence of coinfection: 1 (5.3%) with B. burgdorferi, 1 (5.3%) with B. microti, and 1 (5.3%) with both microorganisms. One patient diagnosed with babesiosis was also seropositive for ehrlichiosis. These results provide evidence for coinfection, perhaps explaining the variable manifestations and clinical responses noted in some patients with tick-transmitted diseases. In certain clinical settings, laboratory testing for coinfection is indicated to ensure that appropriate antimicrobial treatment is given.

Entities:  

Mesh:

Year:  1996        PMID: 8904446      PMCID: PMC228878          DOI: 10.1128/jcm.34.3.724-727.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Simultaneous infection with an Ehrlichia and Borrelia burgdorferi in a child.

Authors:  L L Barton; A Luisiri; J E Dawson; G W Letson; T J Quan
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Simultaneous ehrlichiosis and Lyme disease.

Authors:  L L Barton; J E Dawson; G W Letson; A Luisiri; A J Scalzo
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

3.  Concurrent positive serology for ehrlichiosis and Lyme disease.

Authors:  I Raad; V Singh; T J Quan
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

Review 4.  Tick-borne diseases in the United States.

Authors:  D H Spach; W C Liles; G L Campbell; R E Quick; D E Anderson; T R Fritsche
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

5.  Rickettsiae and Borrelia burgdorferi in ixodid ticks.

Authors:  L A Magnarelli; T G Andreadis; K C Stafford; C J Holland
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

6.  Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut.

Authors:  J F Anderson; E D Mintz; J J Gadbaw; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

7.  Human babesiosis in New York State: an epidemiological description of 136 cases.

Authors:  S C Meldrum; G S Birkhead; D J White; J L Benach; D L Morse
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

8.  Primary and secondary erythema migrans in central Wisconsin.

Authors:  J W Melski; K D Reed; P D Mitchell; G D Barth
Journal:  Arch Dermatol       Date:  1993-06

9.  Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans.

Authors:  P D Mitchell; K D Reed; M F Vandermause; J W Melski
Journal:  Am J Clin Pathol       Date:  1993-01       Impact factor: 2.493

10.  Geographical and temporal distribution of babesial infection in Connecticut.

Authors:  P J Krause; S R Telford; R Ryan; A B Hurta; I Kwasnik; S Luger; J Niederman; M Gerber; A Spielman
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  41 in total

1.  Two tick-borne diseases in one: a case report of concurrent babesiosis and Lyme disease in Ontario.

Authors:  C C dos Santos; K C Kain
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

Review 2.  Laboratory testing for Lyme disease: possibilities and practicalities.

Authors:  Kurt D Reed
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State.

Authors:  S J Wong; G S Brady; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 4.  Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.

Authors:  Maria A Diuk-Wasser; Edouard Vannier; Peter J Krause
Journal:  Trends Parasitol       Date:  2015-11-21

5.  79-year-old man with fever, malaise, and jaundice.

Authors:  Lisa M Baumann Kreuziger; Alfonso J Tafur; Rodney L Thompson
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

6.  Detection of tick-borne pathogens by MassTag polymerase chain reaction.

Authors:  Rafal Tokarz; Vishal Kapoor; James E Samuel; Donald H Bouyer; Thomas Briese; W Ian Lipkin
Journal:  Vector Borne Zoonotic Dis       Date:  2009-04       Impact factor: 2.133

Review 7.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

8.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County.

Authors:  S Varde; J Beckley; I Schwartz
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.